Here, we showed that verteporfin treatment induced activation markers of CD25 in CD4 and CD8+ T cells according to our flow cytometry result, supporting that modulation of the immune response mediated by T cell activation might be one of factors in verteporfin causing tumor suppression in the YAP/AKT CCA mouse model. The gene discussed is CD8A; the disease is cholangiocarcinoma.